Study on Reentry Evaluation Mode for Blood Donors Used to be HBV Reactive in Jiangsu Province.
10.19746/j.cnki.issn.1009-2137.2022.01.044
- Author:
Wen-Jia HU
1
;
Ni-Zhen JIANG
1
;
Shao-Wen ZHU
1
;
Hong LIN
2
Author Information
1. Jiangsu Province Blood Center, Nanjing 210042, Jiangsu Province, China.
2. Jiangsu Province Blood Center, Nanjing 210042, Jiangsu Province, China,E-mail: linhong712003@sina.com.
- Publication Type:Journal Article
- Keywords:
donor reentry;
electrochemiluminescence immunoassay;
hepatitis B surface antigen;
nucleic acid testing;
risk assessment
- MeSH:
Blood Donors;
DNA, Viral;
Hepatitis B;
Hepatitis B Surface Antigens;
Hepatitis B virus/genetics*;
Humans
- From:
Journal of Experimental Hematology
2022;30(1):264-269
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the risk of reentry in HBV reactive blood donors and feasibility of HBV reentry strategy.
METHODS:HBsAg+ or HBV DNA+ donors who had been quarantined for more than 6 months in Jiangsu Province could propose for reentry application. Blood samples were routinely screened by dual-ELISA for HBsAg, anti-HCV, HIV Ab/Ag, and anti- Treponema pallidum and those non-reactive ones were tested by minipool nucleic acid testing (NAT) for three times. To identify occult HBV donors, samples of NAT non-reactive were further tested by electrochemiluminescence immunoassay (ECLIA) for HBV seromarkers (including HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb). Donors of only 4 ECLIA patterns were accepted to reentry, including all 5 HBV seromarkers negative, anti-HBs only but having history of hepatitis B vaccine injection, HBcAb only, HBsAb+ / HBcAb+ with HBsAb more than 200 IU/L. Additionally, the detection rate of HBV infection was compared between routine screening mode and ECLIA, as well as the reentry qualified rate of HBsAg+ and HBV DNA+ blood donors.
RESULTS:From Oct. 2016 to Aug. 2019, a total of 737 HBV reactive donors had applied for reentry, including 667 HBsAg+ reactive and 70 HBV DNA+ reactive donors. Among 3 screening methods, the highest HBV detection rate (43.15%, 318/737) was observed on ECLIA, while only 4.75% (35/737) on ELISA and 3.12% (23/737) on NAT, respectively. Among 4 qualified patterns of HBV serological markers, the highest proportion was found in the all negative group (22.90%, 155/677), followed by the group with HBsAb+ only and history of hepatitis B vaccine injection (19.35%, 131/677), and the median concentration of HBsAb was 237.7 IU/L. The unqualified rate of HBV DNA+ donors was 82.86%, which was significantly higher than 47.98% of HBsAg+ donors.
CONCLUSION:Routine screening tests merely based on ELISA and NAT could miss occult HBV donors and may not be sufficient for blood safety. HBsAb concentration and vaccine injection history should be included in the evaluation of HBV reactive donors who intend to apply for reentry. There is a relatively larger residual risk of occult HBV infection in blood donors quarantined for HBV DNA reactive.
